LL37

LL-37 is a cationic α-helical research peptide derived from the C-terminal region of human cathelicidin (hCAP18). It exhibits broad-spectrum antimicrobial and immunomodulatory activity in preclinical studies, acting via membrane disruption and modulation of TLR/NF-κB pathways. LL-37 is widely used in microbiology and immunology research investigating host defense peptides and innate immune signaling.

For research use only. Not for human consumption.